The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) successfully hosted the "Breast Cancer Update Conference 2024" on June 15th and 16th. The event brought together leading experts, researchers, healthcare professionals, and faculty from India and abroad to explore recent breakthroughs in breast cancer research. The two-day conference highlighted critical findings from the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), and the San Antonio Breast Cancer Symposium (SABCS).

Held under the patronage of Chairman Rakesh Chopra, the conference featured expert-led sessions on emerging therapies, precision medicine, and patient-centered care. It included panel discussions and interactive workshops designed to foster knowledge exchange and collaboration. Topics covered early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and advanced treatment options such as immunotherapy and precision medicine.

Renowned oncologists presented significant findings from recent studies and latest trials on targeted therapies, immunotherapy like Pembrolizumab, cyclin inhibitor tablets, and new drugs and surgical procedures, along with radiation techniques. These presentations provided valuable insights into innovative treatments and patient care strategies.

Dr. D.C. Doval, Chair of Medical Oncology & Chief of Breast & Thoracic Services at RGCIRC and Organizing Chairman, emphasized the importance of such platforms for sharing knowledge and driving advancements in breast cancer treatment. "The Breast Cancer Update Conference 2024 provided an invaluable opportunity for professionals to learn from each other and stay abreast of the latest research and clinical practices worldwide. Our goal is to advance our collective efforts in breast cancer care and improve patient outcomes. Together, we can make significant strides in the fight against breast cancer," he stated.

Dr. Pankaj Goyal, Senior Consultant in Medical Oncology at RGCIRC, highlighted the success of the event, saying, "Our goal is to ensure that the latest advancements in breast cancer research are rapidly translated into clinical practice. This conference has been instrumental in bridging the gap between research and patient care, and we are committed to continuing this momentum."

Interactive panel discussions facilitated robust exchanges of ideas and experiences among top oncologists, researchers, and clinicians. Panels covered critical subjects such as high-risk breast cancer, metastatic breast cancer, and the evolving role of immunotherapy in treatment protocols.

Dr. (Prof) Sudhir Kumar Rawal, Medical Director, noted that the conference has been instrumental in bridging the gap between research and patient care. Dr. Vineet Talwar, Director of Medical Oncology, expressed optimism about the conference's impact. Dr. A.K. Dewan, Director of Surgical Oncology, emphasized that the Breast Cancer Update Conference 2024 represents RGCIRC's ongoing commitment to addressing the complexities of breast cancer.

The Breast Cancer Update Conference 2024 set a new benchmark for collaborative efforts in breast cancer research and treatment, underscoring the importance of shared knowledge and innovation in advancing patient care.